EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
66 hedge funds and large institutions have $14.6M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
66
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$398K | |
| 2 | +$275K | |
| 3 | +$208K | |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$114K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$106K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$486K | |
| 3 | -$363K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$287K |
| 5 |
Renaissance Technologies
New York
|
-$276K |